| Company | Date | Position | Consensus β | Price Target β | 1-Yr Return | vs S&P 500 β |
|---|---|---|---|---|---|---|
|
A
Agilent
|
Aug 27, 2026 | BUY |
Strong Buy
-5.7% avg upside
34 analysts
|
$190.00
13.34% Upside
|
+6.4% | Β· |
|
QDEL
QuidelOrtho
|
Aug 24, 2026 | SELL |
Buy
+267.7% avg upside
13 analysts
|
$12.00
11.50% Upside
|
+25.7% | Β· |
|
ALMR
Alamar Biosciences, Inc.
|
Aug 10, 2026 | BUY |
Strong Buy
-2.6% avg upside
5 analysts
|
$35.00
1.81% Upside
|
+22.8% | Β· |
|
QGEN
Qiagen
|
Aug 10, 2026 | BUY |
Buy
-4.0% avg upside
24 analysts
|
$50.00
11.66% Upside
|
+2.1% | Β· |
|
SHC
Sotera Health
|
Aug 10, 2026 | HOLD |
Strong Buy
+20.0% avg upside
13 analysts
|
$18.00
1.23% Downside
|
-4.0% | Β· |
|
TXG
10x Genomics
|
Aug 10, 2026 | HOLD |
Buy
-41.8% avg upside
19 analysts
|
$50.00
46.49% Downside
|
+59.9% | Β· |
|
NTRA
Natera
|
Aug 07, 2026 | BUY |
Strong Buy
-19.8% avg upside
28 analysts
|
$360.00
12.23% Downside
|
+27.4% | Β· |
|
BRKR
Bruker
|
Aug 06, 2026 | BUY |
Buy
-6.5% avg upside
22 analysts
|
$60.00
5.18% Downside
|
+23.5% | Β· |
|
RVTY
Revvity
|
Aug 06, 2026 | HOLD |
Buy
-23.6% avg upside
23 analysts
|
$110.00
27.39% Downside
|
+30.5% | Β· |
|
WAT
Waters
|
Aug 06, 2026 | HOLD |
Strong Buy
-5.6% avg upside
31 analysts
|
$400.00
5.94% Downside
|
+6.5% | Β· |
|
CAI
Caris Life Sciences, Inc.
|
Aug 06, 2026 | BUY |
Strong Buy
+0.7% avg upside
20 analysts
|
$25.00
11.64% Downside
|
+41.8% | Β· |
|
BLLN
BillionToOne, Inc. Class A
|
Aug 06, 2026 | BUY |
Strong Buy
+19.7% avg upside
10 analysts
|
$130.00
22.76% Upside
|
+32.8% | Β· |
|
CRL
Charles River Labs
|
Aug 05, 2026 | BUY |
Strong Buy
-11.9% avg upside
36 analysts
|
$310.00
6.83% Upside
|
+13.0% | Β· |
|
ICLR
Icon
|
Aug 04, 2026 | HOLD |
Strong Buy
+15.2% avg upside
27 analysts
|
$165.00
1.91% Upside
|
+3.3% | Β· |
|
ILMN
Illumina
|
Aug 04, 2026 | BUY |
Buy
-30.4% avg upside
31 analysts
|
$230.00
15.85% Downside
|
+34.5% | Β· |
|
MTD
Mettler-Toledo
|
Aug 04, 2026 | HOLD |
Hold
-17.9% avg upside
19 analysts
|
$1400.00
5.86% Downside
|
+3.1% | Β· |
|
GH
Guardant Health
|
Aug 04, 2026 | BUY |
Strong Buy
-3.9% avg upside
32 analysts
|
$195.00
9.59% Upside
|
+11.3% | Β· |
|
TEM
Tempus AI, Inc. Class A
|
Aug 04, 2026 | HOLD |
Strong Buy
-8.6% avg upside
24 analysts
|
$45.00
41.31% Downside
|
+62.9% | Β· |
|
AVTR
Avantor
|
Jul 30, 2026 | HOLD |
Buy
+3.4% avg upside
26 analysts
|
$12.00
21.84% Downside
|
+9.7% | Β· |
|
RGEN
Repligen
|
Jul 29, 2026 | BUY |
Strong Buy
-5.8% avg upside
25 analysts
|
$175.00
3.70% Downside
|
+35.3% | Β· |
|
IQV
IQVIA Holdings
|
Jul 29, 2026 | BUY |
Strong Buy
-2.6% avg upside
40 analysts
|
$285.00
10.29% Upside
|
+5.3% | Β· |
|
TMO
Thermo Fisher
|
Jul 28, 2026 | BUY |
Strong Buy
-6.1% avg upside
40 analysts
|
$690.00
5.29% Upside
|
+14.4% | Β· |
|
DHR
Danaher
|
Jul 23, 2026 | BUY |
Strong Buy
-0.0% avg upside
47 analysts
|
$220.00
2.72% Upside
|
+10.0% | Β· |
|
OSUR
Orasure Technologies
|
Aug 09, 2024 | HOLD |
Buy
+115.1% avg upside
11 analysts
|
$5.00
26.10% Upside
|
-34.1% | Β· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.